NDC 71332-005

REZLIDHIA

Olutasidenib

REZLIDHIA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Rigel Pharmaceuticals, Inc.. The primary component is Olutasidenib.

Product ID71332-005_c9a5b2db-b491-4a67-9cfc-c6228f0e3843
NDC71332-005
Product TypeHuman Prescription Drug
Proprietary NameREZLIDHIA
Generic NameOlutasidenib
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-12-01
Marketing CategoryNDA /
Application NumberNDA215814
Labeler NameRigel Pharmaceuticals, Inc.
Substance NameOLUTASIDENIB
Active Ingredient Strength150 mg/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71332-005-01

30 CAPSULE in 1 BOTTLE (71332-005-01)
Marketing Start Date2022-12-01
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [REZLIDHIA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
REZLIDHIA
REZLIDHIA
97683809 not registered Live/Pending
Rigel Pharmaceuticals, Inc.
2022-11-18
REZLIDHIA
REZLIDHIA
88603967 not registered Live/Pending
Forma Therapeutics, Inc.
2019-09-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.